Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

141. Different methods and settings for glucose monitoring for gestational diabetes during pregnancy.

Different methods and settings for glucose monitoring for gestational diabetes during pregnancy. BACKGROUND: Incidence of gestational diabetes mellitus (GDM) is increasing worldwide. Blood glucose monitoring plays a crucial part in maintaining glycaemic control in women with GDM and is generally recommended by healthcare professionals. There are several different methods for monitoring blood glucose which can be carried out in different settings (e.g. at home versus in hospital). OBJECTIVES (...) : The objective of this review is to compare the effects of different methods and settings for glucose monitoring for women with GDM on maternal and fetal, neonatal, child and adult outcomes, and use and costs of health care. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group Trials Register (30 September 2016) and reference lists of retrieved studies. SELECTION CRITERIA: Randomised controlled trials (RCTs) or quasi-randomised controlled trials (qRCTs) comparing different methods

Cochrane2017

142. Physiologic changes of pregnancy: A review of the literature

Physiologic changes of pregnancy: A review of the literature 29234716 2018 11 13 2352-6475 3 4 2017 Dec International journal of women's dermatology Int J Womens Dermatol Physiologic changes of pregnancy: A review of the literature. 219-224 10.1016/j.ijwd.2017.09.003 Throughout pregnancy, the body undergoes a variety of physiologic changes. The cutaneous findings can be most noticeable and often worrisome to both physicians and patients. Obstetricians and dermatologists must be able (...) to differentiate between changes that are benign and those that may be pathologic. Most physicians recognize benign changes that are commonly described in literature such as hyperpigmentation, melasma, striae gravidarum, and telogen effluvium; however, they may be unaware of changes that tend to be less frequently discussed. This comprehensive review provides a broad overview of the physiologic cutaneous changes that occur during pregnancy as described in the literature over the past 10 years. Motosko

International journal of women's dermatology2017 Full Text: Link to full Text with Trip Pro

143. Pregnancy-related venous thromboembolism and risk of occult cancer

Pregnancy-related venous thromboembolism and risk of occult cancer 29296852 2018 11 13 2473-9529 1 23 2017 Oct 24 Blood advances Blood Adv Pregnancy-related venous thromboembolism and risk of occult cancer. 2059-2062 10.1182/bloodadvances.2017010231 The cancer risk during the first year after a pregnancy-related venous thromboembolism episode is higher than expected.An aggressive search for cancer in women with pregnancy-related venous thromboembolism is probably not warranted, due to low

Blood advances2017 Full Text: Link to full Text with Trip Pro

144. Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.

Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes. BACKGROUND: While most guidance recommends the use of insulin in women whose pregnancies are affected by pre-existing diabetes, oral anti-diabetic agents may be more acceptable to women. The effects of these oral anti-diabetic agents on maternal and infant health outcomes need to be established in pregnant (...) women with pre-existing diabetes or impaired glucose tolerance, as well as in women with previous gestational diabetes mellitus preconceptionally or during a subsequent pregnancy. OBJECTIVES: To investigate the effects of oral anti-diabetic agents in women with established diabetes, impaired glucose tolerance or previous gestational diabetes who are planning a pregnancy, or pregnant women with pre-existing diabetes, on maternal and infant health. The use of oral anti-diabetic agents

Cochrane2017

145. Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients.

Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients. Importance: Transfusion of red blood cells from female donors has been associated with increased mortality in male recipients. Objective: To quantify the association between red blood cell transfusion from female donors with and without a history of pregnancy and mortality of red blood cell recipients. Design, Setting, and Participants (...) : Retrospective cohort study of first-time transfusion recipients at 6 major Dutch hospitals enrolled from May 30, 2005, to September 1, 2015; the final follow-up date was September 1, 2015. The primary analysis was the no-donor-mixture cohort (ie, either all red blood cell transfusions exclusively from male donors, or all exclusively from female donors without a history of pregnancy, or all exclusively from female donors with a history of pregnancy). The association between mortality and exposure

JAMA2017

146. Relapsed Hodgkin’s lymphoma in pregnancy: A case review

Relapsed Hodgkin’s lymphoma in pregnancy: A case review 29225679 2018 11 13 1753-495X 10 4 2017 Dec Obstetric medicine Obstet Med Relapsed Hodgkin's lymphoma in pregnancy: A case review. 183-185 10.1177/1753495X17731648 Hodgkin's lymphoma is rarely diagnosed in pregnancy, occurring in 1:6000 deliveries. However, improvements in survival and the use of less gonadotoxic treatments have increased the number of Hodgkin's lymphoma survivors becoming pregnant. Both de novo and relapsed Hodgkin's (...) lymphoma in pregnancy pose difficult decisions for both clinicians and patients. This review discusses important diagnostic and treatment considerations of relapsed Hodgkin's lymphoma in pregnancy. We discuss a difficult case which illustrates these particular dilemmas and suggests the evidence behind different modalities of investigation and management. George-Carey Rhiannon R Homerton University Hospital, London, UK. 4721 Parisaei Maryam M Homerton University Hospital, London, UK. 4721 Koniman Wiece

Obstetric medicine2017 Full Text: Link to full Text with Trip Pro

147. Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy

Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy 28796684 2017 08 10 2017 09 08 2017 09 08 1873-233X 130 3 2017 Sep Obstetrics and gynecology Obstet Gynecol Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy. 599-608 10.1097/AOG.0000000000002191 To evaluate whether quadrivalent human papillomavirus vaccine (4vHPV) administered during the periconceptional (...) period or during pregnancy was associated with increased risks for adverse obstetric events, adverse birth outcomes, or selected major structural birth defects. We conducted a retrospective, observational cohort study using administrative and health care data from the Vaccine Safety Datalink. Insured women 13-27 years old with singleton pregnancies and a live birth from January 1, 2007, through September 1, 2013, who received 4vHPV during the periconceptional period (2 weeks before to 2 weeks after

EvidenceUpdates2017

148. Flurbiprofen Axetil Provides Effective Analgesia Without Changing the Pregnancy Rate in Ultrasound-Guided Transvaginal Oocyte Retrieval: A Double-Blind Randomized Controlled Trial

Flurbiprofen Axetil Provides Effective Analgesia Without Changing the Pregnancy Rate in Ultrasound-Guided Transvaginal Oocyte Retrieval: A Double-Blind Randomized Controlled Trial 28430684 2017 04 21 2017 10 04 2017 10 04 1526-7598 125 4 2017 Oct Anesthesia and analgesia Anesth. Analg. Flurbiprofen Axetil Provides Effective Analgesia Without Changing the Pregnancy Rate in Ultrasound-Guided Transvaginal Oocyte Retrieval: A Double-Blind Randomized Controlled Trial. 1269-1274 10.1213/ANE (...) .0000000000002025 In this prospective double-blind randomized study, we evaluated the analgesic effect and potential effect on pregnancy rate of the nonsteroidal anti-inflammatory drug flurbiprofen axetil in patients undergoing ultrasound-guided transvaginal oocyte retrieval under propofol-remifentanil anesthesia. A total of 200 patients scheduled to undergo ultrasound-guided transvaginal oocyte retrieval were randomly allocated to receive 1.5 mg/kg of flurbiprofen axetil (FA group) or placebo (control group

EvidenceUpdates2017

149. Development of a method to measure experiences of pregnancy-, birth- and postnatal care

Development of a method to measure experiences of pregnancy-, birth- and postnatal care Development of a method to measure experiences of pregnancy-, birth- and postnatal care - NIPH Selected items added to basket Close Vis søkefelt How can we help you today? Search for: Søk Menu • • Development of a method to measure experiences of pregnancy-, birth- and postnatal care Søk i Folkehelsa.no Search for: Søk Infectious diseases & Vaccines Close Mental & Physical health Close Environment (...) & Lifestyle Close Health in Norway Close Quality and Knowledge Close Research & Access to data Close Key message Norwegian Knowledge Centre for the Health Services will conduct a national user experience survey in pregnancy-, birth- and postnatal care in Norway in 2011─2012. Prior to the national survey a development project was carried out. The aim was to develop measurement instruments and methods of data collection. Initially we conducted a literature review. The purpose was to identify existing

Norwegian Institute of Public Health2017

150. Evaluation of Health in Pregnancy grants in Scotland: a natural experiment using routine data

Evaluation of Health in Pregnancy grants in Scotland: a natural experiment using routine data Evaluation of Health in Pregnancy grants in Scotland: a natural experiment using routine data Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue (...) {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} 'Health in Pregnancy' grants were not associated with higher birthweight but do seem to have influenced maternal health-seeking behaviour. {{author}} {{($index , , , , , , & . Alastair H Leyland 1, * , Samiratou Ouédraogo 1 , Julian Nam 2 , Lyndal Bond 3 , Andrew H Briggs 2 , Ron Gray 4 , Rachael Wood 5 , Ruth Dundas 1 1 University of Montréal Hospital Research Centre, University of Montréal, Montréal, QC, Canada 2 The NAM

NIHR HTA programme2017

151. Intrahepatic Cholestasis of Pregnancy: Spontaneous vs in vitro Fertilization

Intrahepatic Cholestasis of Pregnancy: Spontaneous vs in vitro Fertilization 29201793 2018 11 13 2231-5047 7 2 2017 Jul-Dec Euroasian journal of hepato-gastroenterology Euroasian J Hepatogastroenterol Intrahepatic Cholestasis of Pregnancy: Spontaneous vs in vitro Fertilization. 126-129 10.5005/jp-journals-10018-1232 Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disease in pregnancy. Although it was shown that multiple pregnancy and hormone therapies increase the risk (...) of ICP, there is limited information that compared spontaneous fertilization and in vitro fertilization (IVF) from the aspect of developing ICP. In our study, we investigated the potential relationship between ICP and IVF/ spontaneous pregnancy. We reviewed the records (between June 2007 and December 2014) of pregnancies with ICP who were referred to gastroenterology clinics in three different hospitals. Fifty-nine pregnancies (43 spontaneous fertilization, 16 IVF) with ICP were analyzed from

Euroasian journal of hepato-gastroenterology2017 Full Text: Link to full Text with Trip Pro

152. Successful Pregnancies After Adequate Hormonal Replacement in Patients With Combined Pituitary Hormone Deficiencies

Successful Pregnancies After Adequate Hormonal Replacement in Patients With Combined Pituitary Hormone Deficiencies 29264457 2018 11 13 2472-1972 1 10 2017 Oct 01 Journal of the Endocrine Society J Endocr Soc Successful Pregnancies After Adequate Hormonal Replacement in Patients With Combined Pituitary Hormone Deficiencies. 1322-1330 10.1210/js.2017-00005 Women with hypopituitarism have lower pregnancy rates after ovulation induction. Associated pituitary hormone deficiencies might play a role (...) in this poorer outcome. We evaluated fertility treatment and pregnancy outcomes in five women with childhood-onset combined pituitary hormone deficiencies (CPHD). Five women with CPHD were referred for fertility treatment after adequacy of hormone replacement was determined. Patients were subjected to controlled ovarian stimulation (COS) for timed intercourse, intrauterine insemination, or in vitro fertilization, according to the presence or absence of other infertility factors (male or tubal). All women

Journal of the Endocrine Society2017 Full Text: Link to full Text with Trip Pro

153. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.

Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy. BACKGROUND: Pre-eclampsia is considerably more prevalent in low- than high-income countries. One possible explanation for this discrepancy is dietary differences, particularly calcium deficiency. Calcium supplementation in the second half of pregnancy reduces the serious consequences of pre-eclampsia and is recommended by the World Health (...) Organization (WHO) for women with low dietary calcium intake, but has limited effect on the overall risk of pre-eclampsia. It is important to establish whether calcium supplementation before and in early pregnancy has added benefit. Such evidence would be justification for population-level fortification of staple foods with calcium. OBJECTIVES: To determine the effect of calcium supplementation or food fortification with calcium, commenced before or early in pregnancy and continued at least until mid

Cochrane2017

154. Effects of nutrition interventions during pregnancy on low birth weight: an overview of systematic reviews

Effects of nutrition interventions during pregnancy on low birth weight: an overview of systematic reviews 29018583 2018 11 13 2059-7908 2 3 2017 BMJ global health BMJ Glob Health Effects of nutrition interventions during pregnancy on low birth weight: an overview of systematic reviews. e000389 10.1136/bmjgh-2017-000389 Low birth weight (LBW, birth weight less than 2500 g) is associated with infant mortality and childhood morbidity. Poor maternal nutritional status is one of several (...) of randomised controlled trials focusing on nutritional interventions before and during pregnancy to reduce LBW and its components were eligible for inclusion into the overview review. We assessed the methodological quality of the included reviews using A Measurement Tool to Assess Reviews (AMSTAR), PROSPERO: CRD42015024814. We included 23 systematic reviews which comprised 34 comparisons. Sixteen reviews were of high methodological quality, six of moderate and only one review of low quality. Six

BMJ global health2017 Full Text: Link to full Text with Trip Pro

155. Pregnancy in women with Klippel-Trenaunay syndrome: Report of three pregnancies in a single patient and review of literature

Pregnancy in women with Klippel-Trenaunay syndrome: Report of three pregnancies in a single patient and review of literature 29225678 2018 11 13 1753-495X 10 4 2017 Dec Obstetric medicine Obstet Med Pregnancy in women with Klippel-Trenaunay syndrome: Report of three pregnancies in a single patient and review of literature. 177-182 10.1177/1753495X17719181 Klippel-Trenaunay syndrome is characterised by vascular abnormality which increases the risk of thromboembolism and haemorrhage (...) . Physiological changes in pregnancy pose an increased risk to these complications. Being an uncommon disorder, there is limited literature about the management of women with pregnancy and Klippel-Trenaunay syndrome. We report in detail two of three pregnancies in a woman with Klippel-Trenaunay syndrome who had repeated episodes of haematochezia leading to anaemia, managed with Argon laser Photo-Coagulation in pregnancy and also reviewed the complications and the management of pregnant women with Klippel

Obstetric medicine2017 Full Text: Link to full Text with Trip Pro

157. Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study.

Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study. Objective To investigate the association between in utero exposure to antidepressants and risk of psychiatric disorders. Design Population based cohort study. Setting Danish national registers. Participants 905 383 liveborn singletons born during 1998-2012 in Denmark and followed from birth until July 2014, death, emigration, or date of first psychiatric diagnosis (...) , whichever came first. The children were followed for a maximum of 16.5 years and contributed 8.1×10 6 person years at risk. Exposures for observational studies Children were categorised into four groups according to maternal antidepressant use within two years before and during pregnancy: unexposed, antidepressant discontinuation (use before but not during pregnancy), antidepressant continuation (use both before and during pregnancy), and new user (use only during pregnancy). Main outcome measure First

BMJ2017

158. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies

Prenatal screening for and diagnosis of aneuploidy in twin pregnancies ClinicalKey

CMA Infobase (Canada)2017

159. Substance Use in Pregnancy

Substance Use in Pregnancy DEFINE_ME_WA This site requires Cookies to be enabled to function. Please ensure Cookies are turned on and then re-visit the desired page.

Society of Obstetricians and Gynaecologists of Canada2017

160. Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes

Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes DEFINE_ME_WA This site requires Cookies to be enabled to function. Please ensure Cookies are turned on and then re-visit the desired page.

Society of Obstetricians and Gynaecologists of Canada2017